Canndoc To Purchase Better Holdings, 50% Of Cann Pharmaceutical For $35M

InterCure LTd. (TASE: INCR), doing as Canndoc, is poised to acquire brand Better Holdings.

The Israeli cannabis company inked a letter of intent to purchase 100% of Cann Pharmaceutical Ltd.'s shares, including Better’s Israel-based operations and 50% of Cann's shares, for $35 million.

The sum will be payable in InterCure's shares subject to a three-year lock-up period. Up to one-third of the shares will be released each year.

Apart from Israel, Better operates …

Full story available on Benzinga.com

More Canndoc To Purchase Better Holdings, 50% Of Cann Pharmaceutical For $35M